CEO Message
Dear Customers, Collaborative Partners and Friends,
For more than nine years, WuXi AppTec's value proposition has been to provide high-quality R&D services to our customers in a cost-effective and efficient manner. Because of support from our customers, we have been able to achieve solid growth in our global business. On behalf of all WuXi AppTec employees, I want to thank our many loyal customers for your trust and ongoing support.
We are continuing to expand our innovation-driven and fully integrated pharmaceutical, biotechnology and medical device R&D service platform. We extended our leadership position as a global R&D outsourcing company in China by adding operations in the United States in 2008. As one measure of our growth, the total number of WuXi AppTec employees is now over 4,000. We were recently named to the Deloitte Technology Fast 50 China list of rapidly growing Chinese companies for the fifth consecutive year, a Top Ten Chinese Outsourcing Enterprise by China's Ministry of Commerce, a Top Ten Employer for New College Graduates in Pharmaceutical Industry, and ranked 8th on the Fast Company world 50 Most Innovative Companies list. In 2008, we received the Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology.
In response to client demand, WuXi AppTec is actively growing its capabilities. We completed construction of a large-scale manufacturing facility in the Jinshan area of Shanghai, which we expect to be operational in 2010, quadrupling existing capacity. Our Suzhou safety evaluation facility, one of the largest such facilities in Asia, is now operational. Throughout the company, we will continue to build capabilities and capacity to provide you with more and better services in the coming years to assist you in improving the success of research and shortening the time of development.
The focus at WuXi AppTec remains to strengthen our partnership with our global customers so we can help you achieve your strategic goal – finding and bringing to market new life-saving and life-enhancing products – more quickly and cost effectively.
Thank you very much!
Best regards,
Ge Li, Ph.D.
Chairman and Chief Executive Officer